ID: ALA1794873

Max Phase: Preclinical

Molecular Formula: C56H52N4O6S2

Molecular Weight: 941.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@@]1(O)CC(=O)O[C@@H](CSc2nc(-c3ccccc3)c(-c3ccccc3)n2-c2ccccc2)C1.C[C@]1(O)CC(=O)O[C@@H](CSc2nc(-c3ccccc3)c(-c3ccccc3)n2-c2ccccc2)C1

Standard InChI:  InChI=1S/2C28H26N2O3S/c2*1-28(32)17-23(33-24(31)18-28)19-34-27-29-25(20-11-5-2-6-12-20)26(21-13-7-3-8-14-21)30(27)22-15-9-4-10-16-22/h2*2-16,23,32H,17-19H2,1H3/t23-,28+;23-,28-/m11/s1

Standard InChI Key:  QMSIEPWQQFKOOJ-AILPMTMLSA-N

Associated Targets(non-human)

Acyl coenzyme A:cholesterol acyltransferase 1 2344 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 941.19Molecular Weight (Monoisotopic): 940.3328AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Harris NV, Smith C, Ashton MJ, Bridge AW, Bush RC, Coffee EC, Dron DI, Harper MF, Lythgoe DJ, Newton CG..  (1992)  Acyl-CoA:cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.,  35  (23): [PMID:1447739] [10.1021/jm00101a016]

Source